Benzonatate and A-hydrocort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Benzonatate (benzonatate) and A-hydrocort (hydrocortisone sodium succinate). Common drug interactions include pulmonary mass among females and back pain among males.

The phase IV clinical study analyzes what interactions people have when they take Benzonatate and A-hydrocort. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Benzonatate?

Benzonatate has active ingredients of benzonatate. It is often used in cough. eHealthMe is studying from 17,274 Benzonatate users. Check the latest studies of Benzonatate.

What is A-hydrocort?

A-hydrocort has active ingredients of hydrocortisone sodium succinate. eHealthMe is studying from 636 A-hydrocort users. Check the latest studies of A-hydrocort.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

11 people who take Benzonatate and A-hydrocort together, and have interactions are studied.

Benzonatate and A-hydrocort drug interactions.

What are the common drug interactions of Benzonatate and A-Hydrocort, by gender? *:

female:

Pulmonary mass
Renal failure (kidney dysfunction)
Renal injury (kidney injury)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)

male:

Back pain
Chronic kidney disease
Haematochezia (passage of stools containing blood)
Hypotension (abnormally low blood pressure)
Pancreatitis (inflammation of pancreas)
Pneumonia
Renal failure (kidney dysfunction)

What are the common drug interactions of Benzonatate and A-Hydrocort, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Pulmonary mass

40-49:

Chronic kidney disease

50-59:

Malaise (a feeling of general discomfort or uneasiness)

60+:

Back pain
Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Pancreatitis (inflammation of pancreas)
Renal failure (kidney dysfunction)
Renal injury (kidney injury)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 45.45%
Infection: 4 people, 36.36%
High Blood Pressure: 4 people, 36.36%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 27.27%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 27.27%
Tremor (trembling or shaking movements in one or more parts of your body): 3 people, 27.27%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 27.27%
Hypersensitivity: 3 people, 27.27%
Rashes (redness): 3 people, 27.27%
Sleep Disorder: 3 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take Benzonatate and A-hydrocort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously